New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved ...
2025 The Centers for Medicare & Medicaid Services has directed private insurers providing Medicare Advantage plans to cover Biogen's amyotrophic lateral sclerosis drug Qalsody after finding ...
The online system for federal health funding warned of delays due to executive orders after the Trump administration announced a freeze.
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...
The AHA Jan. 27 voiced support for the Centers for Medicare & Medicaid Services proposed rule on policy and technical changes ...
The 2024 eligibility criteria for the four MSPs are detailed below. The Centers for Medicare and Medicaid Services (CMS) will publish updated eligibility criteria in mid-2025. This program can ...
President-elect Donald Trump appears poised to tap a trio of health policy experts to serve as top deputies to Mehmet Oz, his pick to oversee the Centers for Medicare and Medicaid Services ...
The Centers for Medicare and Medicaid Services negotiated prices for a first batch of drugs last year — something it could only do because of the Inflation Reduction Act, which passed in 2022.
President-elect Donald Trump has named Mehmet Oz, a television personality and surgeon, to run the Centers for ... The CMS oversees Medicare and Medicaid, among other services.
Bob Carlson researches all facets of retirement finances. The Centers for Medicare and Medicaid Services (CMS) announced the 2025 inflation-adjusted amounts for Medicare Parts A, B, and D.
The Centers for Medicare and Medicaid Services (CMS) listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top of its list of drugs selected for Medicare negotiation in 2025.
Healthcare delivery involves a financial transaction. Whether it is a total knee replacement or a well-child clinic visit, money is exchanged in return for services. This holds true whether a ...